Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Young J, Bucher H, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Cavassini M, Fux C, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard H, Scherrer A, for the Swiss HIV Cohort Study. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010
18.10.2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
18.10.2010
HIV Med 2010
Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study
Weiter
